1. Home
  2. AHCO vs NEO Comparison

AHCO vs NEO Comparison

Compare AHCO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHCO
  • NEO
  • Stock Information
  • Founded
  • AHCO 2012
  • NEO 2001
  • Country
  • AHCO United States
  • NEO United States
  • Employees
  • AHCO N/A
  • NEO N/A
  • Industry
  • AHCO Medical/Nursing Services
  • NEO Precision Instruments
  • Sector
  • AHCO Health Care
  • NEO Health Care
  • Exchange
  • AHCO Nasdaq
  • NEO Nasdaq
  • Market Cap
  • AHCO 1.2B
  • NEO 1.2B
  • IPO Year
  • AHCO N/A
  • NEO 1999
  • Fundamental
  • Price
  • AHCO $9.07
  • NEO $7.71
  • Analyst Decision
  • AHCO Strong Buy
  • NEO Buy
  • Analyst Count
  • AHCO 5
  • NEO 9
  • Target Price
  • AHCO $13.40
  • NEO $13.31
  • AVG Volume (30 Days)
  • AHCO 1.9M
  • NEO 3.1M
  • Earning Date
  • AHCO 05-06-2025
  • NEO 04-29-2025
  • Dividend Yield
  • AHCO N/A
  • NEO N/A
  • EPS Growth
  • AHCO N/A
  • NEO N/A
  • EPS
  • AHCO 0.58
  • NEO N/A
  • Revenue
  • AHCO $3,246,360,000.00
  • NEO $672,361,000.00
  • Revenue This Year
  • AHCO $1.72
  • NEO $13.95
  • Revenue Next Year
  • AHCO $4.61
  • NEO $11.16
  • P/E Ratio
  • AHCO $15.47
  • NEO N/A
  • Revenue Growth
  • AHCO N/A
  • NEO 10.10
  • 52 Week Low
  • AHCO $7.11
  • NEO $6.08
  • 52 Week High
  • AHCO $11.90
  • NEO $19.11
  • Technical
  • Relative Strength Index (RSI)
  • AHCO 50.14
  • NEO 40.00
  • Support Level
  • AHCO $7.95
  • NEO $7.66
  • Resistance Level
  • AHCO $9.20
  • NEO $8.69
  • Average True Range (ATR)
  • AHCO 0.41
  • NEO 0.75
  • MACD
  • AHCO 0.12
  • NEO 0.03
  • Stochastic Oscillator
  • AHCO 67.65
  • NEO 33.63

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: